Skip to main content
. 2016 Feb 23;5(2):e002640. doi: 10.1161/JAHA.115.002640

Table 6.

Changes in BMI, Weight, and VAT and SAT Measurements From Baseline Prolactin

Outcomea Modelb Women P Value Men P Value Overall P Value
BMI change, kg/m2 Model 1 −0.2 (−0.5 to 0.1) 0.20 −0.2 (−0.5 to 0.2) 0.34 −0.2 (−0.4 to 0.0) 0.10
Model 2 −0.2 (−0.5 to 0.1) 0.17 −0.1 (−0.4 to 0.2) 0.60 −0.2 (−0.4 to 0.0) 0.12
Weight change, kg Model 1 −0.4 (−1.1 to 0.3) 0.27 −0.4 (−1.4 to 0.6) 0.41 −0.4 (−1.0 to 0.2) 0.18
Model 2 −0.5 (−1.2 to 0.3) 0.22 −0.2 (−1.2 to 0.8) 0.70 −0.4 (−0.9 to 0.2) 0.21
VAT volume change, cm3 Model 1 −23.5 (−77.9 to 30.9) 0.40 −4.6 (−125.4 to 116.1) 0.94 −14.1 (−73.5 to −45.3) 0.64
Model 2 −27.5 (−82.6 to 27.5) 0.33 7.8 (−114.4 to 130.1) 0.90 −15.2 (−75.5 to 45.0) 0.62
Model 3 −27.0 (−81.9 to 27.9) 0.34 9.1 (−112.0 to 130.1) 0.88 −15.2 (−75.3 to 45) 0.62
SAT volume change, cm3 Model 1 −41.1 (−133.8 to 51.5) 0.38 −57.9 (−158.0 to 42.2) 0.26 −47.8 (−112.5 to 16.9) 0.15
Model 2 −50.8 (−143.8 to 42.2) 0.29 −36.2 (−137.0 to 64.5) 0.48 −42.2 (−107.5 to 23.0) 0.21
Model 3 −49.8 (−143.0 to 43.3) 0.30 −36.4 (−137.2 to 64.5) 0.48 −42.2 (−107.5 to 23.1) 0.21
VAT attenuation change, HU Model 1 0.19 (−0.34 to 0.72) 0.48 0.57 (−0.17 to 1.30) 0.13 0.34 (−0.08 to 0.76) 0.12
Model 2 0.17 (−0.36 to 0.70) 0.53 0.45 (−0.30 to 1.19) 0.24 0.27 (−0.16 to 0.70) 0.21
Model 3 0.19 (−0.32 to 0.70) 0.46 0.38 (−0.34 to 1.11) 0.30 0.26 (−0.15 to 0.67) 0.21
SAT attenuation change, HU Model 1 0.01 (−0.35 to 0.37) 0.94 −0.03 (−0.52 to 0.46) 0.90 −0.01 (−0.30 to 0.27) 0.94
Model 2 0.01 (−0.36 to 0.37) 0.97 −0.18 (−0.67 to 0.32) 0.49 −0.06 (−0.35 to 0.22) 0.66
Model 3 0.00 (−0.36 to 0.37) 0.98 −0.18 (−0.67 to 0.32) 0.49 −0.07 (−0.35 to 0.22) 0.65

All sex‐interaction P>0.54. BMI indicates body mass index; HU, Hounsfield units; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue.

a

Estimates given change in dependent variable associated with each additional 5‐mg/dL increment in prolactin.

b

Model 1 included age, sex, baseline value of the variable. Model 2 included model 1 plus smoking status and in women, menopausal status. Model 3 included model 2 plus BMI.